ArticleInternational journal of molecular sciences2022

A Novel Human Neutralizing mAb Recognizes Delta, Gamma and Omicron Variants of SARS-CoV-2 and Can Be Used in Combination with Sotrovimab.

Margherita Passariello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.